142 related articles for article (PubMed ID: 19652621)
21. [Resectability of pancreatic head adenocarcinoma].
Lévy P
Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C19-23. PubMed ID: 11787375
[No Abstract] [Full Text] [Related]
22. Prognosis of invasive intraductal papillary mucinous neoplasm.
Longnecker DS; Klöppel G
Pancreas; 2008 Oct; 37(3):333; author reply 333-4. PubMed ID: 18815559
[No Abstract] [Full Text] [Related]
23. Synchronic gastric and pancreatic ductal adenocarcinoma. A case report.
Santos-Fernández J; Arenal-Vera JJ; Cítores-Pascual MÁ; Fernández-Orcajo P; de-Benito-Sanz M; Benito-Fernández C; Tinoco-Carrasco C
Rev Esp Enferm Dig; 2015 Oct; 107(10):642-3. PubMed ID: 26437985
[TBL] [Abstract][Full Text] [Related]
24. Strategies for screening for pancreatic adenocarcinoma in high-risk patients.
Canto MI
Semin Oncol; 2007 Aug; 34(4):295-302. PubMed ID: 17674957
[TBL] [Abstract][Full Text] [Related]
25. Locus/chromosome aberrations in intraductal papillary mucinous neoplasms analyzed by fluorescence in situ hybridization.
Miyabe K; Hori Y; Nakazawa T; Hayashi K; Naitoh I; Shimizu S; Kondo H; Nishi Y; Yoshida M; Umemura S; Kato A; Ohara H; Joh T; Inagaki H
Am J Surg Pathol; 2015 Apr; 39(4):512-20. PubMed ID: 25517961
[TBL] [Abstract][Full Text] [Related]
26. [Strategies for screening for pancreatic adenocarcinoma in high-risk patients].
Béchade D
Bull Cancer; 2011 Jul; 98(7):827-36. PubMed ID: 21684836
[TBL] [Abstract][Full Text] [Related]
27. Endosonography for differentiating benign from malignant intraductal mucinous tumors of the pancreas: is the jury out?
Waxman I
Am J Gastroenterol; 2001 May; 96(5):1323-5. PubMed ID: 11374662
[No Abstract] [Full Text] [Related]
28. Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: correlation with surgical histopathology.
Pais SA; Attasaranya S; Leblanc JK; Sherman S; Schmidt CM; DeWitt J
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):489-95. PubMed ID: 17350894
[TBL] [Abstract][Full Text] [Related]
29. Incidental findings in pancreas screening programs for high-risk individuals: Results from three European expert centers.
Ibrahim IS; Brückner C; Carrato A; Earl J; Inderson A; de Vos Tot Nederveen Cappel WH; Mintziras I; Matthäi E; Figiel J; Wasser M; Moreau H; Bonsing B; Slater EP; Bartsch DK; Vasen HF
United European Gastroenterol J; 2019 Jun; 7(5):682-688. PubMed ID: 31210946
[TBL] [Abstract][Full Text] [Related]
30. A case of pulmonary adenocarcinoma harboring osteoclast-like giant cells: Its evaluation by immunohistochemical and genetic analyses.
Saito R; Fujishima F; Nakamura Y; Hoshikawa Y; Tominaga J; Taniuchi S; Kasajima A; Watanabe M; Okada Y; Sasano H
Pathol Int; 2016 Apr; 66(4):224-9. PubMed ID: 26939759
[TBL] [Abstract][Full Text] [Related]
31. Familial pancreatic cancer syndromes.
Habbe N; Langer P; Sina-Frey M; Bartsch DK
Endocrinol Metab Clin North Am; 2006 Jun; 35(2):417-30, xi. PubMed ID: 16632103
[TBL] [Abstract][Full Text] [Related]
32. Mesenteric venous collateral vessels mimicking cystic pancreatic neoplasm.
Sundaram B; Robbins JB; Zeglis MD; Scheiman JM; Simeone DM; Francis IR
Br J Radiol; 2010 Aug; 83(992):e175-8. PubMed ID: 20675462
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic carcinoma surveillance in patients with familial melanoma.
Parker JF; Florell SR; Alexander A; DiSario JA; Shami PJ; Leachman SA
Arch Dermatol; 2003 Aug; 139(8):1019-25. PubMed ID: 12925390
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic mucinous adenocarcinoma with peritoneal metastases.
Lim WC; Leblanc JK; Chappo JM; Howard TJ; Sherman S
Gastrointest Endosc; 2005 Jul; 62(1):140-1. PubMed ID: 15990837
[No Abstract] [Full Text] [Related]
35. CT for assessment of pancreatic and periampullary cancer.
Andersen HB; Effersøe H; Tjalve E; Burcharth F
Acta Radiol; 1993 Nov; 34(6):569-72. PubMed ID: 8240890
[TBL] [Abstract][Full Text] [Related]
36. Update on familial pancreatic cancer.
Lynch HT; Brand RE; Deters CA; Fusaro RM
Curr Gastroenterol Rep; 2001 Apr; 3(2):121-8. PubMed ID: 11276379
[TBL] [Abstract][Full Text] [Related]
37. The impact on clinical practice of endoscopic ultrasonography used for the diagnosis and staging of pancreatic adenocarcinoma.
Queneau PE; Sauvé G; Koch S; Thibault P; Cléau D; Heyd B; Mantion G; Carayon P
JOP; 2001 May; 2(3):98-104. PubMed ID: 11870331
[TBL] [Abstract][Full Text] [Related]
38. Malignant intraductal papillary mucinous neoplasm of the pancreas: in situ versus invasive carcinoma surgical resectability.
Vullierme MP; Giraud-Cohen M; Hammel P; Sauvanet A; Couvelard A; O'Toole D; Levy P; Ruszniewski P; Vilgrain V
Radiology; 2007 Nov; 245(2):483-90. PubMed ID: 17848678
[TBL] [Abstract][Full Text] [Related]
39. The actual management of early pancreatic cancer.
Iglesias García J; Lariño-Noia J; Domínguez-Muñoz JE
Minerva Gastroenterol Dietol; 2012 Dec; 58(4):321-30. PubMed ID: 23207609
[TBL] [Abstract][Full Text] [Related]
40. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas.
Nagai K; Doi R; Ito T; Kida A; Koizumi M; Masui T; Kawaguchi Y; Ogawa K; Uemoto S
J Hepatobiliary Pancreat Surg; 2009; 16(3):353-8. PubMed ID: 19280108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
